Skip to main content
. 2022 May 6;6(9):2884–2892. doi: 10.1182/bloodadvances.2021006623

Table 2.

Change (T2 − T1) in thrombin generation and its sensitivity to APC or TM, stratified by use of tamoxifen and AIs

Tamoxifen (n=42) Aromatase inhibitors (n=65)
T1 mean (SD) T2 mean (SD) Absolute difference (95% CI) P T1 mean (SD) T2 mean (SD) Absolute difference (95% CI) P
ETP, nM × min 1596.8 (298.5) 1683.0 (297.8) +86.2 (+30.3 to +142.2) .003 1531.3 (252.7) 1575.7 (233.2) +44.4 (−4.2 to +93.1) .07
Thrombin peak, nM 235.4 (65.8) 268.3 (62.5) +32.9 (+21.1 to +44.7) <.001 207.2 (48.4) 214.4 (47.2) +7.2 (−2.5 to +16.9) .13
nAPCsr 0.86 (0.19) 0.97 (0.19) +0.11 (+0.06 to +0.16) <.001 0.84 (0.19) 0.84 (0.19) 0.0 (−0.05 to + 0.05) .91
nTMsr 0.81 (0.35) 1.07 (0.36) +0.26 (+0.19 to +0.33) <.001 0.58 (0.28) 0.60 (0.27) +0.02 (−0.03 to + 0.07) .37